NCT02110563 2024-07-11Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or LymphomaNovo Nordisk A/SPhase 1 Terminated50 enrolled
NCT00049296 2010-06-11Thalidomide and Docetaxel in Treating Patients With Advanced CancerCase Comprehensive Cancer CenterPhase 1 Completed26 enrolled